Sort   by:  
 Page size 
UnknownCombination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC).
Not available
S-EPMC5784559 | biostudies-literature
UnknownTargeting PKCι-PAK1 in EGFR-mutation positive non-small cell lung cancer.
Not available
S-EPMC6835115 | biostudies-literature
Unknownc-Met Mutational Analysis in the Sema and Juxtamembrane Domains in Small-Cell-Lung-Cancer.
Not available
S-EPMC3642244 | biostudies-literature
UnknownProbiotic Supplementation is Associated with Increased Antioxidant Capacity and Copper Chelation in C. difficile-Infected Fecal Water.
Not available
S-EPMC6769851 | biostudies-literature
UnknownCombined FGFR and Akt pathway inhibition abrogates growth of FGFR1 overexpressing EGFR-TKI-resistant NSCLC cells.
Not available
S-EPMC8282882 | biostudies-literature
UnknownThe Effect of Probiotics on Health in Pregnancy and Infants: A Randomized, Double-Blind, Placebo-Controlled Trial.
Not available
S-EPMC12157102 | biostudies-literature
TranscriptomicsExpression data from exposure of BAT and WAT at 6 and 28 degrees C
We run microarrays from three per group Sv129 female mice, ten weeks old, which were maintained at 28M-BM-0C (warm conditions) or 6M-BM-0 C (cold stimulated) for ten days, while standard animal house temperature is 22 M-BM-0C. After ten days, three types of tissue were collected: Brown Adipose Tissu...
ORGANISM(S): Mus musculus 
2014-03-01 | E-GEOD-51080 | biostudies-arrayexpress
ProteomicsCombined FGFR and Akt pathway inhibition abrogate growth of EGFR TKI-resistant NSCLC cells with upregulated FGFR1 expression
Introduction: The clinical benefit of EGFR tyrosine kinase inhibitor (TKI) treatment in non-small cell lung cancer (NSCLC) patients with activating EGFR mutations is temporary, as virtually all patients develop acquired EGFR TKI resistance that occurs via diverse mechanisms. Here, we identified incr...
ORGANISM(S): Homo sapiens (Human) 
2021-07-08 | PXD011803 | Pride
Akt inhibitors Shutgun proteomics 4-plex itraq 
UnknownYB-1 regulates tumor growth by promoting MACC1/c-Met pathway in human lung adenocarcinoma.
Not available
S-EPMC5564630 | biostudies-literature
UnknownCase Report: Identification of a Heterozygous XPA c.553C>T Mutation Causing Neurological Impairment in a Case of Xeroderma Pigmentosum Complementation Group A.
Not available
S-EPMC8415299 | biostudies-literature
Sort   by:  
 Page size